These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9034700)

  • 21. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up.
    Woods SP; Fields JA; Lyons KE; Koller WC; Wilkinson SB; Pahwa R; Tröster AI
    Acta Neurochir (Wien); 2001 Dec; 143(12):1273-7; discussion 1278. PubMed ID: 11810392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired intentional content learning but spared incidental retention of contextual information in non-demented patients with Parkinson's disease.
    Vingerhoets G; Vermeule E; Santens P
    Neuropsychologia; 2005; 43(5):675-81. PubMed ID: 15721180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in Parkinson's disease - a review.
    Wermuth L; Bech P
    Acta Neurol Scand; 2006 Nov; 114(5):360. PubMed ID: 17022788
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral dysfunction in Parkinson's disease.
    Friedman JH
    Clin Neurosci; 1998; 5(2):87-93. PubMed ID: 10785833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver].
    Martínez-Martín P; Guerrero-Díaz MT; Frades-Payo B
    Rev Neurol; 2004 Oct 1-15; 39(7):639-45. PubMed ID: 15490351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT.
    Loo C; Sheehan P; Pigot M; Lyndon W
    J Affect Disord; 2007 Nov; 103(1-3):277-81. PubMed ID: 17706790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving metamemory in ageing and Parkinson's disease.
    Smith SJ; Souchay C; Conway MA
    Age Ageing; 2010 Jan; 39(1):116-9. PubMed ID: 19892743
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefits of physical exercise on executive functions in older people with Parkinson's disease.
    Tanaka K; Quadros AC; Santos RF; Stella F; Gobbi LT; Gobbi S
    Brain Cogn; 2009 Mar; 69(2):435-41. PubMed ID: 19006643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECT for Parkinson's disease.
    Abrams R
    Am J Psychiatry; 1989 Nov; 146(11):1391-3. PubMed ID: 2817111
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of depression in idiopathic Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S112-9. PubMed ID: 12211151
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of depression in Parkinson's disease.
    Sawabini KA; Watts RL
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S37-41. PubMed ID: 15109585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease.
    Cannas A; Solla P; Floris G; Tacconi P; Fulgheri P; Congia S; Spissu A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):138-40. PubMed ID: 16033704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A brief neuropsychological protocol for assessing patients with Parkinson's disease.
    Ong JC; Seel RT; Carne WF; Brown R; Pegg PO; Jehle PJ
    NeuroRehabilitation; 2005; 20(3):191-203. PubMed ID: 16340100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance electroconvulsive therapy for Parkinson's disease.
    Aarsland D; Larsen JP; Waage O; Langeveld JH
    Convuls Ther; 1997 Dec; 13(4):274-7. PubMed ID: 9437571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
    Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H
    Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
    [No Abstract]   [Full Text] [Related]  

  • 39. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
    York MK; Lai EC; Jankovic J; Macias A; Atassi F; Levin HS; Grossman RG
    Acta Neurochir (Wien); 2007; 149(9):857-66; discussion 866. PubMed ID: 17624489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.